Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Koch

Showing results (101-110 of 296) with videos related to

Pageof 30
Sort By:
BJU International|September 13, 2005
Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?Sandra A Armatys, Michael O Koch, Richard Bihrle, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage]M von Eiff, O Koch, N Appelhans, et al.
The Journal of Urology|April 8, 2006
Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinomaEyas M Hattab, Michael O Koch, John N Eble, et al.
The Journal of Urology|December 1, 1990
Physiologic and pathologic alterations associated with ultrasonically generated shock wavesD E Hill, W S McDougal, H Stephens, et al.
Urology Practice|May 21, 2021
Barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer: what's the problem?Clint Cary, Laura Militello, Paige DeChant, et al.
BJU International|June 26, 2003
Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomyD W Brandli, M O Koch, R S Foster, et al.
Human Pathology|November 21, 2021
High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experienceKatrina Collins, Eric Brocken, Clinton D Bahler, et al.
European Cytokine Network|September 22, 2001
Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell deathO Ludwiczek, A Kaser, R O Koch, et al.
Langenbeck'S Archives of Surgery|July 28, 2011
Mesh-reinforced hiatal hernia repair: a review on the effect on postoperative dysphagia and recurrenceStavros A Antoniou, Oliver O Koch, George A Antoniou, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 25, 2015
[Interventional procedures in the treatment of gastroesophageal reflux disease]O O Koch, G Köhler, H Wundsam, et al.
Pageof 30

Showing results (101-110 of 296) with videos related to

Sort By:
Pageof 30
BJU International|September 13, 2005
Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?Sandra A Armatys, Michael O Koch, Richard Bihrle, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage]M von Eiff, O Koch, N Appelhans, et al.
The Journal of Urology|April 8, 2006
Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinomaEyas M Hattab, Michael O Koch, John N Eble, et al.
The Journal of Urology|December 1, 1990
Physiologic and pathologic alterations associated with ultrasonically generated shock wavesD E Hill, W S McDougal, H Stephens, et al.
Urology Practice|May 21, 2021
Barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer: what's the problem?Clint Cary, Laura Militello, Paige DeChant, et al.
BJU International|June 26, 2003
Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomyD W Brandli, M O Koch, R S Foster, et al.
Human Pathology|November 21, 2021
High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experienceKatrina Collins, Eric Brocken, Clinton D Bahler, et al.
European Cytokine Network|September 22, 2001
Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell deathO Ludwiczek, A Kaser, R O Koch, et al.
Langenbeck'S Archives of Surgery|July 28, 2011
Mesh-reinforced hiatal hernia repair: a review on the effect on postoperative dysphagia and recurrenceStavros A Antoniou, Oliver O Koch, George A Antoniou, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 25, 2015
[Interventional procedures in the treatment of gastroesophageal reflux disease]O O Koch, G Köhler, H Wundsam, et al.
Pageof 30